Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Gastrointestinal Stromal Tumors 6 Leukemia, Myeloid, Chronic-Phase 4 Leukemia 4 Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Sarcoma 1 Relapsed Pediatric Solid Tumor 1 Mesothelioma 1 Meningioma 1 Leukemia, Myeloid 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 GIST 1 Drug-Related Side Effects and Adverse Reactions 1 Chordoma 1 Central Nervous System Neoplasms 1 Carcinoma, Adenoid Cystic 1 Brain Neoplasms 1

Interventions

Drug Therapy 4 apatinib 3 Oxaliplatin 3 pemigatinib 2 pembrolizumab 2 cemiplimab 2 avelumab 2 atezolizumab 2 S 1 (combination) 2 Nivolumab 2 Leucovorin 2 Irinotecan 2 Folfox protocol 2 Fluorouracil 2 Everolimus 2 Erlotinib Hydrochloride 2 Endoscopic Mucosal Resection 2 Docetaxel 2 Capecitabine 2 CGX1321 2 vandetanib 1 titanium silicide 1 tepotinib 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sodium thiosulfate 1 selpercatinib 1 rucaparib 1 pralsetinib 1 ponatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Gastrointestinal Neoplasms × Imatinib Mesylate × Clear all

NCT02013089 2016-08-30

GITIC

Sun Yat-sen University

Phase NA Unknown

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡